C Vivek Lal MD, FAAP

Founder, Biostack Ventures

Dr. C. Vivek Lal, M.D. is a physician, scientist, innovator and entrepreneur.

In his academic role, Dr. Lal serves the Clinical Director of Innovation at The Marnix Heersink Institute of Biomedical Innovation, Professor and as the Director of Pulmonary Microbiome Lab at University of Alabama at Birmingham (UAB). As a double board certified neonatal intensivist physician, he serves as the Director of Small Baby Program at UAB, one of the largest neonatal ICU’s in the country.

As a part of Biostack Ventures, Dr. Lal serves as the Founder and CEO of ResBiotic Nutrition, Inc., a company that makes science
backed wellness supplements. He is also the Founder of Alveolus Bio, Inc., a platform biotech company which does FDA approved pulmonary drug development & Urgent Care for Children, a Southeast US based urgent care chain headquartered in AL.

After medical school and residency training, Dr. Lal completed his clinical fellowship and research fellowship at University of Texas at Southwestern, Dallas, TX, followed by an executive program in Drug and Device Development from Massachusetts Institute of Technology (MIT). Dr. Lal’s Microbiome Lab has been funded by NIH-NHLBI and AHA to evaluate the role of the microbiome in the development of diseases. Dr. Lal has published over 100 peer reviewed research manuscripts or abstracts and has several patents under his name as an inventor. He has won several national and international awards in the field of human biology research.

“With Dr. Lal’s expertise as an astute businessman with a solid foundation – that of a world class physician-scientist-innovator, Biostack Ventures is positioned to become a national leader in the health innovation industry”

Dr. Sanjay Singh, PhD
Business Advisor